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ABSTRAK 
PENYAKIT HEMOLISIS JANIN DAN BAYI BARU LAHIR (HDFN) DAN 
HEMOLITIK TRANSFUSI DARAH (HTR) DISEBABKAN ANTIBODI KIDD DI 
HOSPITAL UMUM SARAWAK 
 
Penyakit Hemolisis Janin dan Bayi baru lahir (HDFN) dan penyakit Hemolitik 
Transfusi Darah (HTR) boleh disebabkan oleh antibodi terhadap antigen Kidd. Di 
Malaysia, kelaziman antibodi Kidd menyebabkan HDFN dan HTR telah dilaporkan; 
bagaimanapun masih kekurangan data dari Hospital Umum Sarawak (HUS). Oleh itu 
tujuan kajian ini dijalankan adalah untuk menentukan jika antibodi Kidd menyebabkan 
HDFN dan HTR di HUS. Kes-kes ‘alloimmunisation’ dari tahun 2011 hingga 2014 
telah dikumpulkan daripada rekod perubatan pesakit. Seterusnya, untuk menentukan 
prevalens fenotip Kidd, kajian prospektif telah dilakukan. Dua ratus lima puluh (250) 
penderma darah di HUS dari 1 hingga 10 September 2015 telah direkrut. Sampel darah 
telah diuji untuk kumpulan darah  sistem Kidd  menggunakan kad gel Diamed-ID. 
Keputusan menunjukkan terdapat 1109 kes ‘alloimmunisation’di HUS. Daripada jumlah 
ini 44 (4.0%) kes ‘alloimmunisation’ adalah disebabkan oleh antibodi Kidd dan 1065 
(96.0%) kes adalah disebabkan oleh antibodi jenis lain. Sepuluh (10) daripada 44 kes 
(22.7%) ‘alloimmunisation’ adalah disebabkan oleh antibodi Kidd menyebabkan HDFN 
manakala 4 daripada 44 kes (9.1%) menyebabkan HTR dan keputusan ini menunjukkan 
prevalens yang rendah (p> 0.05). Sementara itu, keputusan fenotip Kidd menunjukkan 
kehadiran fenotip Jk(a+b+) ialah 110 daripada 250 (44.0%) dan fenotip Jk(a-b-) ialah 7 
daripada 250 (2.8%) penderma darah. Fenotip Kidd lain yang dikesan ialah Jk(a+b-) 
iaitu 60 daripada 250 (24.0%) dan Jk(a-b+) iaitu 73 daripada 250 (29.2%) penderma 
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darah. Fenotip Kidd dikesan dalam empat (4) kumpulan etnik; Cina, 127 daripada 250 
(50.8%), Melayu, 96 daripada 250 (38.4%), Bidayuh, 25 daripada 250 (10.0%) dan 
Iban, 2 daripada 250 (0.8%). Keputusan juga menunjukkan bahawa fenotip Jk(a-b-) 
hadir hanya dalam kaum Melayu iaitu 7 daripada 250 (2.8%) tetapi tidak dijumpai di 
dalam kumpulan etnik yang lain, dan penemuan ini adalah signifikan (p <0.05). Kajian 
ini menunjukkan bahawa ‘alloimmunisation’ disebabkan antibodi  Kidd adalah tidak 
biasa bagi HDFN dan HTR di HUS. Fenotip Kidd yang paling kerap di kalangan 
penderma darah  adalah Jk(a+b+). Fenotip Jk(a-b-) dalam ethnik Melayu di Sarawak 
adalah tertinggi berbanding dengan kajian terdahulu di Malaysia dan Asia. 
Kesimpulannya, antibodi Kidd jarang menyebabkan HDFN dan HTR di HUS dan 
kumpulan darah Kidd telah dikategorikan di kalangan penderma darah di HUS. 
 
Kata kunci: Penyakit Hemolisis Janin dan Bayi Baru Lahir (HDFN), Tindak balas 
Hemolisis Transfusi (HTR), antibodi Kidd, fenotip Kidd, ethnik, Hospital Umum 
Sarawak. 
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ABSTRACT 
HAEMOLYTIC DISEASE OF FOETUS AND NEWBORN (HDFN) AND 
HAEMOLYTIC TRANSFUSION REACTION DUE TO KIDD ANTIBODY IN 
HOSPITAL UMUM SARAWAK. 
 
Haemolytic Disease of Foetus and Newborn (HDFN) and Haemolytic Transfusion 
Reaction (HTR) may occur due to antibodies against Kidd antigen. In Malaysia, the 
prevalence of RBC alloimmunization due to Kidd antibody for cases of HDFN and 
HTR have been reported however there is insufficient data in Hospital Umum Sarawak 
(HUS). Therefore, the aim of this study is to determine whether Kidd alloimmunization 
causes HDFN and HTR. Records of alloimmunisation cases from 2011 to 2014 were 
retrieved and traced to the patients’ medical records to determine whether Kidd 
antibodies is the underlying cause of HDFN and HTR in HUS. Secondly, to determine 
the prevalence of Kidd phenotype, two hundred and fifty (250) regular blood donors in 
HUS from 1st to 10th September 2015 were recruited. Blood samples were phenotyped 
for Kidd blood group using Diamed-ID gel card system. The results showed there were 
1109 cases of alloimmunisation recorded. Out of this 44 (4.0%) cases of 
alloimmunisation were due to Kidd antibody and 1065 (96.0%) cases were due to other 
antibodies. Ten (10) out of 44 (22.7%) cases of alloimmunisation were due to Kidd 
antibody resulting in HDFN whilst 4 out of 44 cases (9.1%) resulting in HTR. These 
results were not statistically significant (p> 0.05). Meanwhile, the results of Kidd 
phenotype showed the presence of Jk(a+b+) phenotype in 110 out of 250 (44.0%) and 
Jk(a-b-) phenotype in 7 out of 250 (2.8%) blood donors. The other Kidd phenotypes 
detected were Jk(a+b-) in 60 out of 250 (24.0%) and Jk(a-b+) in 73 out of 250 (29.2%) 
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blood donors. Kidd phenotype was detected in four (4) ethnic groups; Chinese, 127 out 
of 250 (50.8%), Malays, 96 out of 250 (38.4%), Bidayuh, 25 out of 250 (10.0%) and 
Iban, 2 out of 250 (0.8%). The results also showed that Jk(a-b-) phenotype is present 
only in the Malays 7 out of 250 (2.8%) but not found in the other ethnic groups, and this 
is statistically significant (p<0.05). This study shows that alloimmunisation by Kidd 
blood group system is uncommon for the underlying HDFN and HTR in HUS. The 
most common Kidd phenotype among regular blood donors is Jk(a+b+). The prevalence 
of Jk(a-b-) phenotype in Malays in Sarawak is highest compared to earlier studies in 
Malaysia and Asia. In conclusion, there is low prevalence of Kidd antibody causing 
HDFN and HTR and Kidd blood group system was successfully characterised in regular 
blood donors in HUS.  
  
Keywords: Haemolytic Disease of Foetus and Newborn (HDFN), Haemolytic 
Transfusion Reaction (HTR), Kidd blood group system, ethnicity, Hospital Umum 
Sarawak (HUS). 
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CHAPTER 1 
1.1 INTRODUCTION 
Blood transfusion has many benefits but adverse effects may also develop. The 
adverse effects include haemolytic transfusion reaction (HTR), transfusion transmitted 
infection (TTI), allergic reaction and febrile transfusion reaction (Sahu et al., 2014). 
Transfusion reaction is defined as unwanted events that can happen to any patient 
receiving blood transfusion therapy. It can be classified as acute or delayed transfusion 
reaction (Bolton-Maggs and Cohen, 2013).           
Acute haemolytic transfusion reactions are rare, but it can be fatal. It occurs when 
incompatible blood is transfused. This leads to the development of alloantibody 
resulting in destruction of red blood cells (RBC) leading to haemolysis (Shackle) 
As a standard procedure, before any transfusion is given, pre-transfusion testing will 
be done. The pre-transfusion testing consists of ABO and Rh D typing, antibody 
screening test and cross-matching. Once the patients' blood group are known, it is safe 
to provide ABO compatible blood without cross-matching procedure (White et al., 
2016). However, a small group of people may have unexpected antibody against 
donor’s RBC. There is also a possibility that antibody could be undetected by antibody 
screening test due to low titre. Therefore, a cross-match test is an essential step that 
needs to be taken before blood is transfused (Sood et al., 2013).  
Rios (2011) reported that the incidence of acute HTR is one (1) in 76,000 RBC 
transfusions (Rios et al., 2011). The main causes are ABO and Rh incompatible with 
one (1) in 40,000 transfusions followed by non-ABO RBC alloantibodies. Even very 
little amount of incompatible blood transfused could lead to multi-organ failure and 
2 
 
patients may require intensive care and resuscitation. Clerical error may be one of the 
causes of fatal acute HTR (Bolton-Maggs and Cohen, 2013).  
Delayed HTR may occur after 24 hours of receiving incompatible blood 
transfusion. This is due to RBC antibodies reacting with antigens in donor’s RBC. 
These antibodies are produced in the recipients’ blood causing haemolysis (White et al., 
2016). Low antibody levels are one of the causes of delayed HTR and different antigens 
may give different characteristics. The Kidd and Rh antigens commonly cause delayed 
HTR where Kidd antigen may activate the complement system causing severe 
intravascular haemolysis. (Villa et al., 2007) reported a case of fatal HTR due to anti-
Jka antibody. Other antibodies which can cause intravascular haemolysis include anti-P, 
P1, Pk, H and M (Al-Riyami et al., 2014).  
In the Malaysian population, the most common Kidd phenotype is Jk(a+b+) while 
the rarer Kidd phenotype are Jk(a+b-), Jk(a-b+) and Jk(a-b-). Jk(a-b-) phenotype is rare 
in Malaysia (Musa et al., 2012) and other countries (Marion et al., 2004). Individuals 
with Jk(a-b-) Kidd phenotype is often detected during an antibody screening and 
antibody identification test where they may form anti-Jk3 after sensitisation following 
blood transfusion or pregnancy. Kidd antibody and antigen can be detected by urea lysis 
test or molecular technique (Remeikiene, 2014). The consequence of formation of anti-
Jk3 in women is Haemolytic Disease of Foetus and Newborn (HDFN) in subsequent 
pregnancies (Qureshi et al., 2014). Whilst the formation of anti-Jk3 antibody in an 
individual can cause severe HTR if he or she is transfused with either Jka or Jkb 
positive RBC (Yousuf et al., 2014).  
In all ethnic groups, Jk(a+b+) is the commonest Kidd phenotype where Nathalang 
O (2015) reported similar findings in Thai and Asian populations (Nathalang et al., 
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2015). Musa et al (2012) reported the low prevalence of Jk(a-b-) phenotype in blood 
donors in National Blood Centre (NBC), Malaysia. Similar findings were also reported 
in the Polynesians and Japanese where they reported that Jk(a-b-) phenotype is rare 
(Marion et al., 2004, Marli et al., 2014).  
Kidd antibodies may cause delayed HTR (BCSH Guideline, 2014). Fatal HDFN due 
to Kidd antibody was reported by Kim and Lee (2006) where an infant died on the 
fourth day of admission due to intracranial bleed and multiorgan failure despite 
optimum treatment, such as exchange transfusion and intensive phototherapy had been 
given. Anti-Jkb was found in maternal serum and eluate of infant’s blood (Kim and Lee, 
2006).   
In Malaysia, severe HDFN due to anti-Jkb also has been reported by Yousof et al., 
2012. Blood investigations revealed anti-Jkb in the maternal serum and eluate of 
infant’s blood however the child survived despite severe manifestations (Yousuf et al., 
2012). Hassan et al (2014) studied the incidence of HDFN due to maternal RBC 
alloantibodies in the Malay population. It was found that 0.58% women were found to 
have clinically significant RBC alloantibodies. The highest alloantibody was Rh system 
with 56.7% (n=17) followed by MNS system 13.3% (n= 4) and Kidd system 10% (n=3) 
(Hassan et al., 2014).  
Al-Joudi et al (2011) suggested blood donors RBC profile should be matched with 
the patients RBC profile to prevent further alloimmunisation. Certain RBC phenotype 
are common to specific ethnic, race and geographic distributions (Al-Joudi et al., 2011). 
It is best to supply match phenotype blood to prevent complication from blood 
transfusion therapy (Dogra et al., 2015). For this reason, it is essential to increase blood 
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donors’ RBC database from the same ethnic group as the patients’, to meet the demand 
(Rogers et al., 2015).   
There are many requests for Kidd phenotype blood in Malaysia, especially for 
chronic anaemia, and transfusion dependent patients such as thalassaemia patients 
(Figures 1.1, 1.2 and Table 1.1). In Malaysia, based on records of National Blood 
Centre (NBC), there are very limited amount of frozen blood stock available especially 
from the Kidd blood group system.  
Problem arises when regular RBC phenotyping of blood donors are only practised 
in NBC and not in all other blood collection centers in Malaysia. Hence, phenotyped 
blood is requested only from the NBC when needed. The blood requested may take 
several days to be supplied and transfused to the patients. This may lead to delay in 
patient management and may have consequences on patient prognosis and outcome. 
Table 1.1 Data of phenotype blood requests at National Blood Centre, Kuala Lumpur for 2015 
(Unpublished data report on phenotype blood request from Immunohaematology Department, 
National Blood Centre Kuala Lumpur, 2015). 
 Phenotype Total (n)       (%) 
Rh 4346 46.02 
Kidd 1779 18.84 
Duffy 596 6.31 
MNS 1686 17.85 
Lewis 512 5.42 
Kell 137 1.45 
P1  62 0.66 
Bombay 5 0.05 
Mut (Mia) 253 2.68 
Others 67 0.71 
 
9443 100 
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Figure 1.1. Kidd phenotyped blood requests at National Blood Centre, Kuala Lumpur in 2015, 
n=1779. (Unpublished data report on phenotype blood request from Immunohaematology 
Department, National Blood Centre, Kuala Lumpur, 2015). 
 
 
 
Figure 1.2 Phenotyped blood requests according to patients’ diagnosis in National Blood 
Centre, Kuala Lumpur for July 2015, n=519 (Unpublished data report on phenotype blood 
request from Immunohaematology Departrment, National Blood Centre, Kuala Lumpur, 2015). 
940
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In Malaysia, the prevalence of Kidd alloimmunisation for cases of HDFN and HTR 
has been reported however there is insufficient data in Hospital Umum Sarawak (HUS). 
Therefore, the aim of this study is to identify Kidd alloimmunization that implicate 
HDFN and HTR. Additionally, the prevalence of Kidd phenotype in different ethnic 
groups of regular blood donors in HUS was investigated.  
 
1.1 Rationale of Study 
Sources of rare blood supply are from blood donors (fresh blood), patients’ own 
siblings and frozen blood bank (Chaudhari, 2009). The target of this study is to increase 
rare blood donor pool in Malaysia registry and reduce the incidence of RBC 
alloimmunisation among transfusion dependent patients by giving matched phenotype 
blood. 
There are many requests of Kidd phenotype blood in Malaysia, especially for 
chronic anaemia, haemato-oncology patients and transfusion dependent patients 
(thalassaemia patients), but in the NBC, there are very limited frozen blood (Kidd 
phenotype specific blood) to be supplied based on the statistic of phenotype blood 
request in NBC 2015. Since some types of Kidd phenotypes are rare among Malaysian 
population, the blood is kept in the freezer for many years.  
Incompatible Kidd blood transfusion can cause severe acute or delayed HTR 
(Caamaño et al., 2015). Blood with same phenotype is needed to prevent HTR (Al-
Joudi et al., 2011). In HUS Sarawak, random regular RBC phenotyping for blood 
donors is not practiced. Therefore, if patients are in need of Kidd phenotype blood, it 
has to be requested from the NBC. 
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When a rare blood type is requested for a patient, the rare donor registry in NBC can 
be utilized to locate donors negative for a high-prevalence antigen or negative for 
multiple common antigens to ensure the patient receives compatible blood. Hence, we 
should track and organize rare donor information in blood collection centres in an effort 
to better meet the needs of patients with rare blood types in Malaysia and whole 
Borneo. 
When blood is phenotypically matched, the patient has a lower risk of developing 
complications from transfusion therapy (Dogra et al., 2015). Hence, it is extremely 
important to increase the number of available blood donors from all ethnic groups to 
meet the patients’ demand. In this study, we chose Sarawakian as a study subject. 
Indirectly, this study will help HUS to set their own rare donor registry and to supply 
matched phenotype blood to Sarawakian without delay.  
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CHAPTER 2 
LITERATURE REVIEW 
Kidd blood group is one of the major blood group system. Kidd antigens are 
located on a red blood cell urea transporter. It contains alleles Jka and Jkb. It has 4 Kidd 
phenotypes: Jk(a+b+), Jk(a+b-), Jk(a-b+) and Jk(a-b-) (Agarwal et al., 2013). Jk(a-b-) is 
the rarest in most populations, found in 0.9% Polynesians (Marion et al., 2004).  
The gene encoding Kidd phenotype protein is found on chromosome 18. The 
Kidd blood group system is important in transfusion medicine (White et al., 2016). This 
can lead to haemolytic transfusion reaction (HTR), in which the body destroys the 
transfused blood, leading to low red blood cell counts. Another disease associated with 
the Kidd antigen is Haemolytic Disease of Foetus and Newborn (HDFN), in which a 
pregnant woman's body creates antibodies against the blood of her foetus, leading to 
destruction of the foetal blood cells (Velasco Rodríguez et al., 2014).  
Prevalence of red cell phenotype including Kidd phenotype has been published 
in many countries including Malaysia (Musa et al., 2012), India (Joshi and Vasantha, 
2012), China (Zhong et al., 2012), New York (Marion et al., 2004), Nigeria (Osaro et 
al., 2015), Thailand (Nathalang et al., 2015) and Japan (Marli et al., 2014). These 
studies found that the prevalence of the typed antigens among Malaysian blood donors 
to be statistically different to those in the Caucasian and Black populations, but more 
similar to the Asian racial groups. 
Kidd antibody is the commonest cause of delayed HTR (Bolton-Maggs and 
Cohen, 2013). Delayed HTR generally occurs after 24 hours post blood transfusion. 
Affected patients could possibly develop fever, leucocytosis, sign and symptom of 
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anaemia, elevation of serum bilirubin and positive direct coomb’s test reported by de 
Montalembert (de Montalembert et al., 2011).  
Delayed HTR occur after RBC sensitization. Either from previous blood 
transfusion or pregnancy. Kidd antibody has amnestic response if re-expose with the 
same Kidd antigen. Many cases of DHTR are unnoticed due to slow destruction of RBC 
(Rios et al., 2011). Plaut in 1953 discovered anti-Jkb can cause DHTR (Tantalo et al., 
1989).  
Management of HTR due to antibody mediated is to discontinue the transfusion 
while maintaining venous access for emergency management. Anticipate hypotension, 
renal failure, and Disseminated Intravascular Coagulopathy (DIC) (Sachan et al., 2015). 
Prophylactic measures to reduce the risk of renal failure may include low-dose 
dopamine (1-5 mcg/kg/min), vigorous hydration with crystalloid solutions (3000 mL/m 
2/24 h), and osmotic diuresis with 20% mannitol (100 mL/m 2/bolus, followed by 30 
mL/m 2/h for 12 h). If DIC is documented and bleeding requires treatment, transfusions 
of fresh frozen plasma, pooled cryoprecipitates for fibrinogen, and platelet concentrates 
may be indicated (Al-Riyami et al., 2014). 
A clerical check of the information on the blood unit label and the patient's 
identification should be performed to ensure that the "right" blood unit was 
administered to the "right" patient. The residual contents of the blood component 
container should be returned to the blood bank, together with a freshly collected blood 
sample from the patient, and a transfusion reaction investigation should be initiated by 
Transfusion Medicine blood bank team (WHO Blood Safety., 2011). 
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Konstad and Halvonrsen in 1958 reported the first case of HDFN caused by anti-
Jkb.  Keir (2014) studied regarding HDFN due to Kidd antibody which is IgG in nature 
that can cross the placenta and caused HDFN. It can activate complement system and 
leads to intra and extravascular haemolysis in infant (Keir et al., 2014). 
A case study about severe HDFN due to anti-Jkb was reported in Malaysia and 
Korea. Bennardello (2015) proved that the prevalence of HDFN depends on RBC 
antigen negative that differs within ethnic and population. Antenatally, the first 
indication of HDFN caused by Kidd antibody is the presence of anti-Jka or anti-Jkb in 
maternal serum by indirect coomb’s test (Bennardello et al., 2015).  
Clinical symptoms of HDFN infant varies from mild to severe. In mild cases, 
infant may develop mild neonatal jaundice. In moderate to severe HDFN cases, infant 
frequently presented with severe neonatal jaundice, pallor and hepatosplenomegaly. 
Kernicterus is a complication of severe neonatal jaundice and may leads to neurological 
impairment (Illanes Sá, 2013). Antenatally, hydrop fetalis, polyhydramnion, pericardial 
effusion, pleural effusion, ascites, hepatosplenomegaly and placenta may be thickened 
in severe cases of HDFN (Black and Maheshwari, 2009). The full blood picture shows 
anaemia, nucleated red blood cell and polychromasia reported by Gupte S. C (Gupte, 
2015).  
The prevalence of HDFN caused by unexpected alloantibodies have been 
published in many countries including Malaysia (Hassan et al., 2014), Japan (Okutsu et 
al., 2011) and India (Pahuja et al., 2011); with differing  prevalence among these 
countries. In Malaysia, Rh and Kidd were the commonest antibodies causing HDFN 
while in India, it was mostly due to Rh antibody. In Japan, HDFN was mostly due to M 
and N antibodies.  
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Majority of HDFN is caused by high maternal antibody titre. Mild cases require 
close monitoring of patients while moderate to severe HDFN cases usually requires 
resuscitation, intensive support, transfusion and correction of metabolic acidosis (Illanes 
Sá, 2013).  
The spectrum of HDFN has changed over the last few decades. With the 
implementation of RhD immunoprophylaxis, HDFN due to ABO incompatibility and 
other alloantibodies has now emerged as major causes of this condition. Though in 
developing countries, anti D is still a common antibody in pregnant women, many 
Asian countries have identified alloantibodies other than anti D as a cause of moderate 
to severe HDFN (Bennardello et al., 2015). 
Many developed nations have national screening programs for pregnant women. 
This is necessary to ensure timely availability of antigen negative blood and reduce 
effects on the newborn. Although universal screening seems justified, the cost and 
infrastructure required would be immense. Developing countries and under resourced 
nations need to consider universal antenatal screening and frame guidelines accordingly 
(Gupte, 2015). 
The transfusion medicine services Malaysia are currently studying the 
implications and feasibility to implement a more comprehensive screening programme 
of blood groups and antibodies in pregnant women to enable early foetal-neonatal 
intervention (Yousuf et al., 2012). In addition, knowledge of the RBC phenotype 
frequency in a population with different ethnic origins can contribute in creating a donor 
data bank. The database on the distribution of blood groups are essential in providing 
compatible blood for patients with multiple alloantibodies to reduce the RBC 
alloimmunisation and complications (Al-Joudi et al., 2011).  
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Furthermore, blood banks may also maintain a rare blood type database from 
amongst their regular voluntary donors and it may be practical to develop 
cryopreservation facilities for rare donor units (Musa et al., 2012). 
 
2.2 Conceptual Framework 
Figure 2.1 and Figure 2.2 are conceptual framework developed for this study. 
Clinical manifestations due to Kidd antibody can be assessed by using indicators such 
as types of Kidd antibody, types of clinical manifestations (HDFN, HTR and others), 
and history of blood transfusion in affected patients. This study examined the 
demographic profile of regular blood donors in Hospital Umum Sarawak to determine 
associated factors with Kidd phenotypes. The demographic profiles are ABO blood 
group, Kidd phenotype and ethnicity of blood donors.  
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Figure 2.1: Conceptual framework of the study (Kidd antibody). Clinical manifestations due to 
Kidd antibody can be assessed by using indicators such as types of Kidd antibody, types of 
clinical manifestations (HDFN, HTR and others), and history of blood transfusion in affected 
patients. 
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Figure 2.2: Conceptual framework of the study (Kidd phenotype). This study examined the 
demographic profile of regular blood donors in Hospital Umum Sarawak (HUS) and to 
determine the associated factors with Kidd phenotypes. The demographic profiles are ABO 
blood group, ethnicity and barcode of blood donation.  
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CHAPTER 3 
 
RESEARCH QUESTIONS, OBJECTIVES AND HYPOTHESIS 
3.1 Research Question 
1. What is the prevalence of Kidd alloimmunisation for Haemolytic Disease of 
Foetus and Newborn (HDFN) and Haemolytic Transfusion Reaction (HTR) in 
Hospital Umum Sarawak (HUS)? 
2. What are the characteristics of regular blood donors by ethnicity, ABO blood 
group and Kidd phenotypes in HUS? 
3. What is the relationship between ABO blood group, Kidd phenotype and 
ethnicity among regular blood donors in HUS? 
 
3.2 Objectives 
3.2.1 General Objective 
To determine the prevalence of Kidd alloimmunization for cases of HDFN and HTR 
and to investigate the frequency of ABO blood group, Kidd phenotype and its 
association with ethnicity in regular blood donors in HUS. 
3.2.2 Specific Objectives 
1. To determine the prevalence of HDFN cases among Kidd antibody in HUS. 
2. To determine the prevalence of HTR cases among Kidd antibody in HUS.  
3. To determine the frequency of ABO blood group, Kidd phenotype and its 
association with ethnicity in regular blood donors in HUS. 
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3.3 Study Hypotheses 
Null hypothesis  
1. There is no prevalence of HDFN among Kidd antibody cases in HUS. 
2. There is no prevalence of HTR among Kidd antibody cases in HUS. 
3. There is no significant difference between ABO blood group, Kidd phenotypes 
and ethnicity among regular blood donors in HUS.    
Alternative hypothesis 
1. There is prevalence of HDFN among Kidd antibody cases in HUS. 
2. There is prevalence of HTR among Kidd antibody cases in HUS. 
3. There is significant difference between ABO blood group, Kidd phenotypes and 
ethnicity among regular blood donors in HUS.    
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CHAPTER 4 
MATERIALS AND METHODS 
4.1 Study Design 
This study design is a combination of retrospective and cross sectional study. 
 
4.2 Study Duration 
The study duration period was from 1st July 2015 until 30th June 2016. 
Retrospectively, data from 1st January 2011- 31th December 2014 (4 years) was 
collected and analysed. Cross sectional study for Kidd phenotyping, sample from 
1stSeptember 2015 until 10th September 2015 was collected and analysed.  
 
4.3 Study Location 
This study was conducted in Blood Bank of Hospital Umum Sarawak (HUS). HUS 
is the largest hospital in the state of Sarawak, Malaysia. It is the main tertiary and 
referral hospital in Sarawak. HUS currently has more than 1000 beds and offers many 
specialisations services. HUS offers subspecialties in Medicine: nephrology, 
dermatology, neurology, rheumatology, chest medicine, cardiology, infectious diseases, 
gastroenterology and haematology. 
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4.4 Reference Population 
All blood donors in HUS and all antibody positive in HUS. 
4.4.1 Source Population 
 All regular blood donors in HUS and all Kidd antibody positive patients in HUS. 
4.4.2 Sampling Frame 
Two hundred fifty (250) healthy regular blood donors who donated in Blood 
Bank HUS was studied. All eligible blood donors who were fit to donate blood were 
approached for this study. They were explained regarding this study and informed 
consent were taken. Before undergoing blood donation all subjects were required to fill 
Donor History Questionnaire (Appendix J) and were examined by a qualified medical 
doctor. Only subjects who pass the medical examination were enrolled into the study to 
ensure the safety of subjects. Each subject was anonymised to ensure confidentiality.     
Retrospectively, all Kidd alloimmunisation for cases of HTR, HDFN and others 
that was diagnosed by doctors in HUS since 2011 until 2014 was collected and 
analysed. The detailed medical history was extracted from patients’ medical record and 
kept in data proforma.  
4.5 Inclusion and Exclusion Criteria 
Inclusion criteria for patients:  
a) Alloimmunization positive cases due to Kidd Antibody.  
b) Kidd antibody for HTR cases. 
c) Kidd antibody for HDFN cases. 
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Inclusion criteria for blood donors:  
a) Regular blood donor- defined as blood donor who has donated their blood 
yearly with negative result for all virology screening markers.  
b) Eligible blood donor who fulfilled the criteria for blood donor as stated in 
National Guidelines for blood donation. (Transfusion Practice Guideline for 
Clinical and Laboratory Personnel 3rd edition 2008). 
Exclusion criteria for patients:  
a) Alloimmunisation positive cases caused by other antibody. 
b) Other antibody except Kidd that cause HTR. 
c) Other antibody except Kidd that cause HDFN. 
d) Cases of Kidd autoantibody. 
Exclusion criteria for blood donors:  
a) First time blood donors 
b) Foreigner 
c) Non-eligible blood donor according to National Guidelines for blood donation. 
(Transfusion Practice Guideline for Clinical and Laboratory Personnel 3rd 
edition 2008). 
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4.6 Sample Size Calculation   
Sample size for Kidd antibody: According to presence data of Kidd antibody 
positive in antibody identification in HUS for 4 years (from 2011 until 2014). 
Sample size calculation for Kidd antibody using single proportion,  
p=0.1 (10% of total RBC alloantibodies, cited by (Hassan et al., 2014) 
N = (z/∆)² × p(1-p)                                          P=0.6 , z=1.96  ∆=20% 
    = (1.96/0.2)² × 0.1(1-0.1) + 20% drop out                                           
    = 96.04 x 0.09  
    = 8.64 + 20% (1.72) 
    = 10 
Sample size calculation for Kidd antigen: Sample was calculated based on 
proportion from a study done by Williams et. al (Williams et al., 2011). 
a = 0.05 
Power = 0.8 (80%) 
Po= 0.1 
P1= 0.2 (20% of total population; cited by Musa et al, 2012 (Musa et al., 2012) 
m= 1 
n= 219 
+-10% drop out= 219+22 
Sample size =241  
OR Sample size manually calculation, using Pocock’s Formula for two proportions.  
n=p1(1-p1)+p0(1-p0) x (zα + zβ)2 
             (p1-p0)2 
=[0.245(1-0.245)+0.1(1-0.1)] x (1.96+0.84)2 
             (0.245-0.1)2 
